Lisa Nonnenmacher

The effects of PI3K-mediated signalling on glioblastoma cell behaviour

Julia Langhans, Lukas Schneele, Nancy Trenkler et al. · Oncogenesis · 2017 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Bortezomib Primes Glioblastoma, Including Glioblastoma Stem Cells, for TRAIL by Increasing tBid Stability and Mitochondrial Apoptosis

Thomas Unterkircher, Silvia Cristofanon, Sri Hari Krishna Vellanki et al. · Clinical Cancer Research · 2011 · 84 citations

Life Sciences, Cell Biology, Oncology +17

Immune phenotypes predict survival in patients with glioblastoma multiforme

Haouraa Mostafa, Andrej Paľa, Josef Högel et al. · Journal of Hematology & Oncology · 2016 · 81 citations · Full text

Medicine, Immunology, Oncology +17

Inhibition of NF-κB Signaling Ablates the Invasive Phenotype of Glioblastoma

Mike‐Andrew Westhoff, Shaoxia Zhou, Lisa Nonnenmacher et al. · Molecular Cancer Research · 2013 · 72 citations · Full text

Medicine, Cell Biology, Oncology +17

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect

Georg Karpel‐Massler, Richard E. Kast, Mike‐Andrew Westhoff et al. · Journal of Neuro-Oncology · 2014 · 63 citations

Medicine, Oncology, Pharmacology +16